Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Astrazeneca R&d Boston patentsThe following is a sampling of recent Astrazeneca R&d Boston patent applications (USPTO Patent Application #, Patent Title) sorted by month.
March 2008 - Astrazeneca R&d Boston patents
20080076780 - Combination of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent 20080064691 - Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity February 2008 - Astrazeneca R&d Boston patents
20080045481 - Novel co-crystal 20080045517 - 6h-thieno[2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh) 20080045521 - Phenylalanine derivatives January 2008 - Astrazeneca R&d Boston patents
20080027076 - Pyrimidines with tie2 (tek) activity 20080020416 - Enzyme and preparation method 20080021012 - 3-[4-{6-substituted alkanoyl pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents 20080009482 - Novel compounds 20080009512 - Tetrahydroquinolones and aza-analogues thereof for use as dpp-iv inhibitors in the treatment of diabetes 20080004302 - Novel compounds December 2007 - Astrazeneca R&d Boston patents
20070298413 - Topoisomerase modulators assays 20070287703 - Fused pyrimidones useful in the treatment and the prevention of cancer 20070281916 - Substituted isoxazolines and their use as antibacterial agents November 2007 - Astrazeneca R&d Boston patents
20070275954 - Novel fused heterocycles and uses thereof 20070275982 - Method 20070270384 - Process and intermediate 20070259849 - Azine-carboxamides as anti-cancer agents October 2007 - Astrazeneca R&d Boston patents
20070249636 - Selected fused heterocyclics and uses thereof August 2007 - Astrazeneca R&d Boston patents
20070202548 - Screening assay to identify inhibitors of the murd enzyme using an activator-independent murd enzyme 20070185106 - Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists 20070185185 - Derivatives of thienopyrrole as gnrh antagonists July 2007 - Astrazeneca R&d Boston patents
20070172425 - Testing cell cycle regulation effect of a compound using a hollow fibre cell implant 20070167428 - Thienopyrroles as antagonists of gnrh June 2007 - Astrazeneca R&d Boston patents
20070149560 - Novel fused triazolones and the uses thereof 20070142413 - Pyrazole derivatives as inhibitors of receptor tyrosone kinases 20070135455 - Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of tie2 May 2007 - Astrazeneca R&d Boston patents
20070123528 - Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity 20070117138 - Splice variant cannabinoid receptor (cb1b) April 2007 - Astrazeneca R&d Boston patents
20070092879 - Fluoresence-based dna primase assays February 2007 - Astrazeneca R&d Boston patents
20070043069 - Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase 20070037888 - 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer January 2007 - Astrazeneca R&d Boston patents
20070010556 - Thiophene derivatives as chk 1 inhibitors December 2006 - Astrazeneca R&d Boston patents
20060287241 - Combination comprising n-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate 20060287379 - Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer 20060281666 - Substitute thiophenes and uses therof November 2006 - Astrazeneca R&d Boston patents
20060270637 - Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents 20060270689 - Novel fused heterocycles and uses thereof 20060270692 - Chemical compounds 20060263298 - Assay 20060264494 - Heterocyclic amide derivatives which process glycogen phorylase inhibitory activity 20060258710 - Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists 20060252781 - Fused heterocycles as inhibitors of glutamate racemase(muri) October 2006 - Astrazeneca R&d Boston patents
20060235067 - 6h-thieno[2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh) 20060223801 - Pyrrol derivatives with antibacterial activity September 2006 - Astrazeneca R&d Boston patents
20060216774 - Method 20060211760 - Indolamide derivatives which possess glycogen phosphorylase inhibitory activity 20060199966 - Indol-2-amides as glycogen phosphorylase inhibitors August 2006 - Astrazeneca R&d Boston patents
20060194260 - Screening assays for cannabinoid-ligand-type modulators of gpr55 20060178382 - Chinazoline derivatives as aurora kinase inhibitors 20060173034 - Novel 4-anilinoquinoline-3-carboxamides July 2006 - Astrazeneca R&d Boston patents
20060166288 - Assay for the screening of compounds acting through erbb-2
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Astrazeneca R&d Boston in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Astrazeneca R&d Boston with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|